In vitro and in vivo characterization of biodegradable enoxacin microspheres

Eur J Pharm Biopharm. 2000 Mar;49(2):191-4. doi: 10.1016/s0939-6411(99)00086-7.


The in vitro release and plasma concentration profiles of sustained release enoxacin microspheres intended for the treatment of bone and systemic infections due to sensitive strains of bacteria were investigated. Microspheres of enoxacin were prepared by using poly(glycolic acid-co-DL-lactic acid) (PLGA) by the emulsion solvent evaporation technique and characterized by in vitro release in an incubator, and in vivo release in the rat subcutaneous model. The microspheres were spherical in nature, and particle size range had a significant influence on the in vitro release. The enoxacin plasma concentration 2 h after the administration of treatments was two-fold higher in animals who received the free drug compared with those who received microspheres of size range 125-250 microm. The plasma of animals who received the free drug was depleted of enoxacin by the end of the first day. However, the plasma concentration of enoxacin in the animals who received microspheres was sustained above 0.5 microg/ml for about 8 days. The results show that biodegradable microspheres of enoxacin can be prepared which release the antibiotic in vivo for days following a subcutaneous administration. This should provide a means for the sustained treatment of infections due to sensitive strains of bacteria.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Anti-Infective Agents / administration & dosage*
  • Biodegradation, Environmental
  • Delayed-Action Preparations
  • Enoxacin / administration & dosage*
  • Enoxacin / chemistry
  • Enoxacin / pharmacokinetics
  • Male
  • Microspheres
  • Rats
  • Rats, Sprague-Dawley
  • Solubility


  • Anti-Infective Agents
  • Delayed-Action Preparations
  • Enoxacin